| Product Code: ETC6190113 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Though MERS-CoV cases are rare in Australia, the country remains vigilant due to global travel and importation risks. The market is defined by preparedness measures, surveillance systems, and potential vaccine development strategies aligned with global health guidelines to counter the Middle East Respiratory Syndrome threat.
Although Middle East Respiratory Syndrome (MERS) cases in Australia are rare, the market remains vigilant due to global travel and biosecurity concerns. The focus is on preparedness, with stockpiling of antiviral drugs and investment in rapid diagnostic capabilities to address potential outbreaks.
The MERS market in Australia is constrained by the rarity of cases, which limits commercial incentives for treatment or diagnostic development. Public and clinical awareness remains low due to the absence of recent outbreaks in the region, reducing preparedness levels and funding.
Although Middle East Respiratory Syndrome (MERS) cases are rare in Australia, the market holds potential for proactive investments. Developing diagnostic platforms and stockpiling antiviral drugs as part of national biosecurity measures offers opportunities, particularly for companies engaged in infectious disease preparedness. Government partnerships for emergency response solutions can provide a reliable investment return over time.
Though Australia has not had local outbreaks of Middle East Respiratory Syndrome (MERS), government policies are proactive, focusing on border health security and international traveler screening. The Biosecurity Act 2015 empowers authorities to manage risks of exotic respiratory syndromes, including MERS. Public health response planning and alignment with World Health Organization (WHO) protocols ensure that Australia remains prepared for any future outbreaks involving MERS or similar syndromes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Respiratory Syndrome (MERS) Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Respiratory Syndrome (MERS) Market - Industry Life Cycle |
3.4 Australia Respiratory Syndrome (MERS) Market - Porter's Five Forces |
3.5 Australia Respiratory Syndrome (MERS) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Respiratory Syndrome (MERS) Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Australia Respiratory Syndrome (MERS) Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.8 Australia Respiratory Syndrome (MERS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Respiratory Syndrome (MERS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about respiratory diseases and their impacts on public health |
4.2.2 Technological advancements in diagnostic tools and treatment options for respiratory syndrome |
4.2.3 Growing research and development activities focused on finding new therapies and vaccines for respiratory syndromes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new drugs and treatments for respiratory syndrome |
4.3.2 Limited availability of specialized healthcare facilities for managing respiratory syndromes |
4.3.3 High treatment costs associated with managing respiratory syndrome cases |
5 Australia Respiratory Syndrome (MERS) Market Trends |
6 Australia Respiratory Syndrome (MERS) Market, By Types |
6.1 Australia Respiratory Syndrome (MERS) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By REGN3048, 2021- 2031F |
6.1.4 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By REGN3051, 2021- 2031F |
6.1.5 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By GLS-5300, 2021- 2031F |
6.1.6 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Respiratory Syndrome (MERS) Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Respiratory Syndrome (MERS) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Respiratory Syndrome (MERS) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Australia Respiratory Syndrome (MERS) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Respiratory Syndrome (MERS) Market Import-Export Trade Statistics |
7.1 Australia Respiratory Syndrome (MERS) Market Export to Major Countries |
7.2 Australia Respiratory Syndrome (MERS) Market Imports from Major Countries |
8 Australia Respiratory Syndrome (MERS) Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on respiratory syndrome treatments |
8.2 Percentage of population vaccinated against respiratory syndromes |
8.3 Rate of adoption of new diagnostic tools and technologies for respiratory syndrome detection and management. |
9 Australia Respiratory Syndrome (MERS) Market - Opportunity Assessment |
9.1 Australia Respiratory Syndrome (MERS) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Respiratory Syndrome (MERS) Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Australia Respiratory Syndrome (MERS) Market Opportunity Assessment, By End users, 2021 & 2031F |
9.4 Australia Respiratory Syndrome (MERS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Respiratory Syndrome (MERS) Market - Competitive Landscape |
10.1 Australia Respiratory Syndrome (MERS) Market Revenue Share, By Companies, 2024 |
10.2 Australia Respiratory Syndrome (MERS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here